echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Zhangjiang Biopharmaceutical's three-year target of achieving sales revenue of 80 billion yuan in 2017

    Zhangjiang Biopharmaceutical's three-year target of achieving sales revenue of 80 billion yuan in 2017

    • Last Update: 2020-05-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
      By 2017, Zhangjiang, as the main carrier to undertake Shanghai's construction of high-end biopharmaceutical product manufacturing center, innovation research and development center and medical service center in the Asia-Pacific region, continues to grow rapidly in terms of industrial scale, with total economic and manufacturing output value accounting for more than 40% of Shanghai's total economic output value, further improving industrial efficiency, and maintaining a leading position in industrial innovation.  Reporters learned that Zhangjiang High-Tech Park Management Committee recently accepted the Ministry of Industry and Information Technology to create a "national new industrial demonstration base" review, in the formulation of the next three years to create a work programme, Zhangjiang biopharmaceutical industry put forward the above clear new three-year goals.  The target sits on: by the end of 2017, sales revenue will be 80 billion yuan, total industrial output value is 45 billion yuan, and total revenue from research and development and technical services will exceed 15 billion yuan.  To accept the review of the Ministry of Industry and Information Technology It is understood that the three-year creation of the work programme is in the State Ministry of Industry and Information Technology on the "national new industrial demonstration base" to implement dynamic management, every three years to review the background.  In the first half of 2010, the Zhangjiang High-Tech Park Management Committee decided to declare biomedicine as the leading industry to create a "national demonstration base for new industrialization industry", covering the Zhangjiang Biopharmaceutical Base, Zhangjiang Dong District, International Medical Park and Kangqiao Industrial Park Biopharmaceutical Industrialization Base, and successfully passed the Shanghai Municipal Commission for Information and Development, officially declared in May 2010.  On October 20, the same year, with the support of the Shanghai Municipal Economic and Information Commission, the research team of the Ministry of Industry and Information Technology went to Zhangjiang to investigate, listened to Zhangjiang's report on the creation of a national demonstration base for new industrialization industry with the biopharmaceutical base industry, fully affirmed the advantages and development prospects of Zhangjiang's biopharmaceutical industry, and placed high expectations on Zhangjiang's biopharmaceutical industry, and decided at the end of 2010 to award Zhangjiang as the "National New Industrialization Industry Demonstration Base" in the field of biopharmaceutical industry.  In accordance with the requirements of the national new industrial demonstration base construction, after more than three years of active creation, Zhangjiang Biomedicine National New Industrialization Industry Demonstration Base has become China's biopharmaceutical field of innovative talent concentration, the most outstanding results of new drug creation, the most significant industrial cluster advantages of the region, industrial output value, products and innovation development capacity to maintain a good upward development trend.  Recently, under the overall arrangement of the Shanghai Municipal Economic and Information Commission, Zhang Jiang fully implemented the preparation of the review materials, in addition to the declaration of the creation of the work programme and industrial development planning to determine the objectives and tasks, in addition to the formulation of the next three years to create a work programme.  The next three years objectives are determined According to the specific task arrangement, in the next three years, Zhangjiang will focus on optimizing the regional layout of industrial development, consolidating the development advantages of key areas, actively promoting the large-scale development of the industry and improving the support system for research and development and industrial development.  Among them, enterprise innovation, energy level improvement will become an important goal According to the plan, by 2017, Zhangjiang biopharmaceutical industry annual sales revenue of more than 1 billion yuan of enterprises will reach 14, more than 500 million yuan of enterprises 30, more than 100 million yuan of enterprises 80, biopharmaceutical high-tech enterprises 150.  In addition, in terms of research and development innovation objectives: research and development of innovative drugs 30, including a class of new drugs 3, research and development of three types of medical device products 30, identified biopharmaceutical enterprises research and development institutions 120.  Reporters from The Shanghai Pudong New Area Bio-Industry Industry Association learned that in Zhangjiang has established a leading biomedical innovation system, and cultivate a large number of innovative enterprises.  By the end of last year, the total industrial output value of The Top 10 biopharmaceutical enterprises in Zhangjiang amounted to 18.7 billion yuan, accounting for 47.6% of the total output value of biopharmaceuticals in Pudong New Area Over 18 biological enterprises, more than 1 billion yuan of 4, in the overall development of key areas, leading enterprises and fist products, to achieve economic scale expansion and industrial energy level upgrading.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.